SEK 0.97
(-1.62%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | -43 Thousand SEK | -100.02% |
2022 | 240.42 Million SEK | 15.44% |
2021 | 208.25 Million SEK | 9.91% |
2020 | 189.47 Million SEK | 25.24% |
2019 | 151.28 Million SEK | 41.03% |
2018 | 107.27 Million SEK | 81.74% |
2017 | 59.02 Million SEK | 12.23% |
2016 | 52.59 Million SEK | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 55.44 Million SEK | -1.85% |
2024 Q2 | 62.64 Million SEK | 12.99% |
2023 Q2 | 62.47 Million SEK | -3.67% |
2023 FY | -43 Thousand SEK | -100.02% |
2023 Q1 | 64.85 Million SEK | 21.07% |
2023 Q4 | 56.48 Million SEK | 17.9% |
2023 Q3 | 47.91 Million SEK | -23.31% |
2022 FY | 240.42 Million SEK | 15.44% |
2022 Q4 | 53.57 Million SEK | -2.42% |
2022 Q3 | 54.9 Million SEK | -18.15% |
2022 Q2 | 67.07 Million SEK | 3.38% |
2022 Q1 | 64.87 Million SEK | 35.55% |
2021 Q2 | 59.83 Million SEK | 9.51% |
2021 FY | 208.25 Million SEK | 9.91% |
2021 Q3 | 45.92 Million SEK | -23.24% |
2021 Q4 | 47.86 Million SEK | 4.21% |
2021 Q1 | 54.63 Million SEK | 5.25% |
2020 FY | 189.47 Million SEK | 25.24% |
2020 Q4 | 51.91 Million SEK | 19.38% |
2020 Q2 | 47.5 Million SEK | 1.98% |
2020 Q3 | 43.48 Million SEK | -8.46% |
2020 Q1 | 46.57 Million SEK | -5.98% |
2019 Q2 | 38.82 Million SEK | 24.89% |
2019 FY | 151.28 Million SEK | 41.03% |
2019 Q4 | 49.54 Million SEK | 55.61% |
2019 Q3 | 31.83 Million SEK | -17.99% |
2019 Q1 | 31.08 Million SEK | -6.07% |
2018 Q2 | 30.29 Million SEK | 60.05% |
2018 Q3 | 24.95 Million SEK | -17.61% |
2018 Q1 | 18.92 Million SEK | -0.02% |
2018 Q4 | 33.09 Million SEK | 32.6% |
2018 FY | 107.27 Million SEK | 81.74% |
2017 FY | 59.02 Million SEK | 12.23% |
2017 Q2 | 14.71 Million SEK | 9.44% |
2017 Q3 | 13.2 Million SEK | -10.25% |
2017 Q4 | 18.93 Million SEK | 43.35% |
2017 Q1 | 13.44 Million SEK | 0.0% |
2016 FY | 52.59 Million SEK | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
AddLife AB (publ) | 3.01 Billion SEK | 100.001% |
Biotage AB (publ) | 637 Million SEK | 100.007% |
Bonesupport Holding AB (publ) | 510.93 Million SEK | 100.008% |
Doxa AB (publ) | -259.5 Million SEK | 99.983% |
Elekta AB (publ) | 3.39 Billion SEK | 100.001% |
iZafe Group AB (publ) | 35.92 Million SEK | 100.12% |
Ortivus AB (publ) | 48.45 Million SEK | 100.089% |
Ortivus AB (publ) | 48.45 Million SEK | 100.089% |
S2Medical AB (publ) | 20.3 Million SEK | 100.212% |
Synsam AB (publ) | 3.76 Billion SEK | 100.001% |